{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T20:59:06Z","timestamp":1782507546358,"version":"3.54.5"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T00:00:00Z","timestamp":1673568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Acute kidney injury (AKI) is a frequent complication in patients with hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) and is associated with high rates of mortality. We aimed to estimate serum high mobility group protein 1 (HMGB1) levels in hepatitis B virus-related acute-on-chronic liver failure patients and analyze their clinical value in the development and outcomes of Acute kidney injury.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> A total of 251 consecutive patients with hepatitis B virus-related acute-on-chronic liver failure were enrolled in this retrospective study. Using the International Club of Ascites staging criteria of Acute kidney injury, 153 patients developed Acute kidney injury. The clinical data of patients were collected and serum levels of high mobility group protein 1 were measured by ELISA. All patients were followed up until death or for a minimum of 3\u00a0months. Early prediction and prognostic implications of high mobility group protein 1 in Hepatitis B Virus-Related Acute-on-Chronic Liver Failure Patients with Acute Kidney Injury were investigated in different cohorts, including a propensity score-matched ACLF cohort.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Among all individuals with hepatitis B virus-related acute-on-chronic liver failure, the incidence of Acute kidney injury was 61.0% (153\/251). The patients who developed stage 2\/3 Acute kidney injury showed the highest high mobility group protein 1 levels, followed by those who developed stage 1 Acute kidney injury, and those without Acute kidney injury showed the lowest high mobility group protein 1 levels. Moreover, high mobility group protein 1 levels were significantly higher in non-survivors than in survivors among hepatitis B virus-related acute-on-chronic liver failure patients with Acute kidney injury. Furthermore, analysis of the area under the receiver operating characteristic curve (AUROC) indicated that serum high mobility group protein 1 levels (pre-matching: AUC = 0.740; post-matching: AUC = 0.661) may be a potential predictive factor for Acute kidney injury development and that high mobility group protein 1 (AUC = 0.727) might be a reliable biomarker for prognosis in patients with Acute kidney injury.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> In patients with hepatitis B virus-related acute-on-chronic liver failure, Acute kidney injury is universal. Acute kidney injury and its stages negatively influence the 90-day transplant-free mortality rate. Serum high mobility group protein 1 levels can serve as a positive predictor of Acute kidney injury development, and high mobility group protein 1 might also be a prognostic biomarker for Acute kidney injury among hepatitis B virus-related acute-on-chronic liver failure patients.<\/jats:p>","DOI":"10.3389\/fphar.2022.1031790","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T09:29:06Z","timestamp":1673602146000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Determination of HMGB1 in hepatitis B virus-related acute-on-chronic liver failure patients with acute kidney injury: Early prediction and prognostic implications"],"prefix":"10.3389","volume":"13","author":[{"given":"Yu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongying","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longshan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yating","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiefei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueqiu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.jhep.2014.12.029","article-title":"Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the international Club of ascites","volume":"62","author":"Angeli","year":"2015","journal-title":"J. hepatology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.clinre.2015.06.009","article-title":"Biomarkers of oxidation stress, inflammation, necrosis and apoptosis are associated with Hepatitis B-related acute-on-chronic liver failure","volume":"40","author":"Cai","year":"2016","journal-title":"Clin. Res. hepatology gastroenterology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s11010-014-1978-6","article-title":"The role of HMGB1-RAGE axis in migration and invasion of hepatocellular carcinoma cell lines","volume":"390","author":"Chen","year":"2014","journal-title":"Mol. Cell. Biochem."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.2215\/CJN.00910116","article-title":"Urinary biomarkers at the time of AKI diagnosis as predictors of progression of AKI among patients with acute cardiorenal syndrome","volume":"11","author":"Chen","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol. CJASN"},{"key":"B5","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.apsb.2016.02.004","article-title":"The role of high mobility group box 1 (HMGB1) in the pathogenesis of kidney diseases","volume":"6","author":"Chen","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"key":"B6","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/jhbp.770","article-title":"High-mobility group protein B1: A predictive biomarker for hepatic encephalopathy after transjugular intrahepatic portosystemic shunt","volume":"27","author":"Chen","year":"2020","journal-title":"J. Hepatobiliary Pancreat. Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"735425","DOI":"10.3389\/fphys.2021.735425","article-title":"Osthole blocks HMGB1 release from the nucleus and confers protective effects against renal ischemia-reperfusion injury","volume":"12","author":"Dai","year":"2021","journal-title":"Front. Physiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2867241","DOI":"10.1155\/2020\/2867241","article-title":"Evaluation of the biomarkers HMGB1 and IL-6 as predictors of mortality in cirrhotic patients with acute kidney injury","volume":"2020","author":"de Oliveira Gomes","year":"2020","journal-title":"Mediat. Inflamm."},{"key":"B9","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1007\/s10753-021-01565-1","article-title":"Performance of high mobility protein group 1 and interleukin-6 as predictors of outcomes resulting from variceal bleeding in patients with advanced chronic liver disease","volume":"45","author":"Dos Santos Pinheiro","year":"2022","journal-title":"Inflammation"},{"key":"B10","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jhep.2010.05.004","article-title":"EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis","volume":"53","year":"2010","journal-title":"J. Hepatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/ki.2009.422","article-title":"Urinary liver-type fatty acid-binding protein predicts adverse outcomes in acute kidney injury","volume":"77","author":"Ferguson","year":"2010","journal-title":"Kidney Int."},{"key":"B12","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/1744-9987.13736","article-title":"Early biochemical markers in the assessment of acute kidney injury in children after cardiac surgery","volume":"26","author":"Galic","year":"2022","journal-title":"Ther. Apher. Dial."},{"key":"B13","doi-asserted-by":"publisher","first-page":"5220226","DOI":"10.1155\/2021\/5220226","article-title":"Release of HMGB1 in podocytes exacerbates lipopolysaccharide-induced acute kidney injury","volume":"2021","author":"Gao","year":"2021","journal-title":"Mediat. Inflamm."},{"key":"B14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1432-1033.1973.tb03026.x","article-title":"A new group of chromatin-associated proteins with a high content of acidic and basic amino acids","volume":"38","author":"Goodwin","year":"1973","journal-title":"Eur. J. Biochem."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3780","DOI":"10.3892\/ol.2020.11714","article-title":"MicroRNA-218 modulates activities of glioma cells by targeting HMGB1","volume":"8","author":"Gu","year":"2016","journal-title":"Am. J. Transl. Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2478\/jtim-2021-0047","article-title":"Assessment of 17 clinically available renal biomarkers to predict acute kidney injury in critically ill patients","volume":"9","author":"Hou","year":"2021","journal-title":"J. Transl. Int. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s12664-021-01201-8","article-title":"Baseline serum cystatin C as a marker of acute kidney injury in patients with acute-on-chronic liver failure","volume":"40","author":"Jha","year":"2021","journal-title":"Indian J. gastroenterology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/s12967-015-0663-1","article-title":"HMGB1\/RAGE induces IL-17 expression to exaggerate inflammation in peripheral blood cells of Hepatitis B patients","volume":"13","author":"Jhun","year":"2015","journal-title":"J. Transl. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1111\/jvh.13287","article-title":"Prevalence and short-term outcome of acute kidney injury in patients with acute-on-chronic liver failure: A meta-analysis","volume":"27","author":"Jiang","year":"2020","journal-title":"J. viral Hepat."},{"key":"B20","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/cr.2017.51","article-title":"Intracellular HMGB1 as a novel tumor suppressor of pancreatic cancer","volume":"27","author":"Kang","year":"2017","journal-title":"Cell Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1038\/ki.2011.261","article-title":"Chronic kidney disease worsens sepsis and sepsis-induced acute kidney injury by releasing High Mobility Group Box Protein-1","volume":"80","author":"Leelahavanichkul","year":"2011","journal-title":"Kidney Int."},{"key":"B22","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00011-013-0624-1","article-title":"Blockade of high-mobility group box-1 ameliorates acute on chronic liver failure in rats","volume":"62","author":"Li","year":"2013","journal-title":"Inflamm. Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"25487","DOI":"10.1038\/srep25487","article-title":"Characteristics, diagnosis and prognosis of acute-on-chronic liver failure in cirrhosis associated to hepatitis B","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1111\/liv.13443","article-title":"Development of predisposition, injury, response, organ failure model for predicting acute kidney injury in acute on chronic liver failure","volume":"37","author":"Maiwall","year":"2017","journal-title":"Liver Int."},{"key":"B25","doi-asserted-by":"publisher","first-page":"bio058852","DOI":"10.1242\/bio.058852","article-title":"Soluble receptor for advanced glycation end products protects from ischemia- and reperfusion-induced acute kidney injury","volume":"11","author":"Miyagawa","year":"2022","journal-title":"Biol. open"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1007\/s11255-021-03050-y","article-title":"High mobility group box 1 and homocysteine as preprocedural predictors for contrast-induced acute kidney injury after percutaneous coronary artery intervention","volume":"54","author":"Mo","year":"2022","journal-title":"Int. Urol. Nephrol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jacc.2011.10.854","article-title":"Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study","volume":"59","author":"Nickolas","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s12072-008-9106-x","article-title":"Acute-on-chronic liver failure: consensus recommendations of the asian pacific association for the study of the liver (APASL)","volume":"3","author":"Sarin","year":"2009","journal-title":"Hepatol. Int."},{"key":"B29","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s12072-014-9580-2","article-title":"Acute-on-chronic liver failure: consensus recommendations of the asian pacific association for the study of the liver (APASL) 2014","volume":"8","author":"Sarin","year":"2014","journal-title":"Hepatol. Int."},{"key":"B30","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1007\/s12072-019-09980-1","article-title":"Correction to: Acute-on-chronic liver failure: consensus recommendations of the asian pacific association for the study of the liver (APASL): an update","volume":"13","author":"Sarin","year":"2019","journal-title":"Hepatol. Int."},{"key":"B31","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/SHK.0b013e3181df0433","article-title":"Protective effect of high-mobility group box 1 blockade on acute liver failure in rats","volume":"34","author":"Takano","year":"2010","journal-title":"Shock (Augusta, Ga)"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1084\/jem.20120189","article-title":"Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release","volume":"209","author":"Venereau","year":"2012","journal-title":"J. Exp. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1590\/S0004-2803.201800000-75","article-title":"Evaluation of the behavior of levels of Hmgb1 and Il6 as predictors of infection, acute kidney injury and mortality in cirrhotic patients with variceal bleeding","volume":"55","author":"Vilela","year":"2018","journal-title":"Arq. Gastroenterol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/hep.27210","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American association for the study of liver diseases and the European association for the study of the liver","volume":"60","author":"Vilstrup","year":"2014","journal-title":"Hepatology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"9432","DOI":"10.3748\/wjg.v19.i48.9432","article-title":"Cystatin C is a biomarker for predicting acute kidney injury in patients with acute-on-chronic liver failure","volume":"19","author":"Wan","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1136\/gutjnl-2017-314641","article-title":"Development of diagnostic criteria and a prognostic score for Hepatitis B virus-related acute-on-chronic liver failure","volume":"67","author":"Wu","year":"2018","journal-title":"Gut"},{"key":"B37","doi-asserted-by":"publisher","first-page":"4990941","DOI":"10.1155\/2021\/4990941","article-title":"Correlation and diagnostic value of serum cys-C, RBP4, and NGAL with the condition of patients with traumatic acute kidney injury","volume":"2021","author":"Ye","year":"2021","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.amjms.2017.03.005","article-title":"Risk factors and outcomes of acute kidney injury in patients with hepatitis B virus-related acute-on-chronic liver failure","volume":"353","author":"Yuan","year":"2017","journal-title":"Am. J. Med. Sci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"100176","DOI":"10.1016\/j.jhepr.2020.100176","article-title":"Acute-on-chronic liver failure: Definitions, pathophysiology and principles of treatment","volume":"3","author":"Zaccherini","year":"2021","journal-title":"JHEP Rep. innovation hepatology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/1471-2369-14-245","article-title":"Placental growth factor, pregnancy-associated plasma protein-A, soluble receptor for advanced glycation end products, extracellular newly identified receptor for receptor for advanced glycation end products binding protein and high mobility group box 1 levels in patients with acute kidney injury: a cross sectional study","volume":"14","author":"Zakiyanov","year":"2013","journal-title":"BMC Nephrol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s12072-016-9756-z","article-title":"Incidence, risk factors and outcomes of acute kidney injury (AKI) in patients with acute-on-chronic liver failure (ACLF) of underlying cirrhosis","volume":"10","author":"Zang","year":"2016","journal-title":"Hepatol. Int."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e110626","DOI":"10.1371\/journal.pone.0110626","article-title":"The association of HMGB1 expression with clinicopathological significance and prognosis in hepatocellular carcinoma: a meta-analysis and literature review","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1080\/21655979.2021.2024686","article-title":"Combination therapy of Ulinastatin with Thrombomodulin alleviates endotoxin (LPS) - induced liver and kidney injury via inhibiting apoptosis, oxidative stress and HMGB1\/TLR4\/NF-\u03baB pathway","volume":"13","author":"Zhang","year":"2022","journal-title":"Bioengineered"},{"key":"B44","doi-asserted-by":"publisher","first-page":"118203","DOI":"10.1016\/j.lfs.2020.118203","article-title":"HMGB1 in kidney diseases","volume":"259","author":"Zhao","year":"2020","journal-title":"Life Sci."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1031790\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T09:29:14Z","timestamp":1673602154000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1031790\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,13]]},"references-count":44,"alternative-id":["10.3389\/fphar.2022.1031790"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.1031790","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,13]]},"article-number":"1031790"}}